Author:
Combrink Keith D.,Gulgeze H. Belgin,Thuring Jan W.,Yu Kuo-Long,Civiello Rita L.,Zhang Yi,Pearce Bradley C.,Yin Zhiwei,Langley David R.,Kadow Kathleen F.,Cianci Christopher W.,Li Zhufang,Clarke Junius,Genovesi Eugene V.,Medina Ivette,Lamb Lucinda,Yang Zheng,Zadjura Lisa,Krystal Mark,Meanwell Nicholas A.
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference21 articles.
1. Fundamental structure–Activity relationships associated with a new structural class of respiratory syncytial virus inhibitor
2. Respiratory syncytial virus inhibitors. Part 2: Benzimidazol-2-one derivatives
3. Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo
4. Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability
5. For Part 5 of this series, see: Wang, X. A.; Cianci, C. W.; Yu, K.-L.; Combrink, K. D.; Thuring, J. W.; Zhang, Y.; Civiello, R. L.; Kadow, K. F.; Roach, J.; Li, Z.; Langley, D. R.; Krystal, M.;. Meanwell, N. A. Bioorg. Med. Chem. Lett., in press.
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献